Elevation Oncology, Inc. Common stock (ELEV) Dividend History

Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for patients with genomically defined cancers. The company aims to address unmet medical needs by targeting genetic alterations driving tumor growth, with a focus on oncology therapeutics.

101 Federal Street, Boston, MA, 02110
Phone: (716) 371-1125
Website: https://www.elevationoncology.com

Dividend History

Elevation Oncology, Inc. Common stock currently does not pay dividends

Company News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders

Halper Sadeh LLC is investigating several companies for potential violations of securities laws and breaches of fiduciary duties to shareholders, including Flowserve Corporation, Elevation Oncology, Inc., M2i Global, Inc., and Crown Electrokinetics Corp.

GlobeNewswire Inc.

Featured Companies: FLS
Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

The article discusses the promising developments in cancer research, including new therapies and innovative technologies, and highlights recent updates from several biotech companies working on cutting-edge cancer treatments.

Benzinga

Featured Companies: ADPT NEO ONCY ORIC
5 Penny Stocks To Watch Before Next Week; Time To Buy?

Penny stocks to watch before next week. The post 5 Penny Stocks To Watch Before Next Week; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: VRM
Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year?

Here is how Elevation Oncology, Inc. (ELEV) and Senesco Technologies Inc. (ELOX) have performed compared to their sector so far this year.

Zacks Investment Research

Page data last updated 07/23/2025 07:14:17 UTC